NEXGEL (NXGLW) Expected to Announce Quarterly Earnings on Monday

NEXGEL (NASDAQ:NXGLWGet Free Report) is projected to issue its resultson Monday, May 18th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $3.9090 million for the quarter.

NEXGEL Trading Down 8.0%

NXGLW opened at $0.05 on Monday. The business’s fifty day moving average is $0.07 and its two-hundred day moving average is $0.16. NEXGEL has a one year low of $0.04 and a one year high of $0.44.

About NEXGEL

(Get Free Report)

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.

Further Reading

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.